Bosentan for the treatment of adult pulmonary hypertension

By Dwyer Nathan   Kilpatrick David  

Future Cardiology, Vol. 7, Iss. 1, 2011-01 ,pp. : 19-37

Future Medicine

Access to resources Recommend Favorite

Review on Bosentan, A Dual Endothelin Receptor Antagonist for the Treatment of Pulmonary Arterial Hypertension

By  

Recent Patents on Cardiovascular Drug Discovery, Vol. 5, Iss. 3, 2010-01 ,pp. : 184-195

Bentham Science Publishers

Access to resources Recommend Favorite

N-Terminal probrain natriuretic peptide as a biochemical marker in the evaluation of bosentan treatment in systemic-sclerosis-related pulmonary arterial hypertension

By Dimitroulas Theodoros   Giannakoulas Georgios   Karvounis Haralambos   Koliakos Georgios   Sfetsios Tilemahos   Dimitroula Hara   Settas Loukas  

Clinical Rheumatology, Vol. 27, Iss. 5, 2008-05 ,pp. : 655-658

Springer Publishing Company

Access to resources Recommend Favorite

Severe polymyositis and flare in autoimmunity following treatment with adalimumab in a patient with overlapping features of polyarthritis and scleroderma

By Liozon E.   Ouattara B.   Loustaud-Ratti V.   Vidal E.  

Scandinavian Journal of Rheumatology, Vol. 36, Iss. 6, 2007-01 ,pp. : 484-486

Informa Healthcare

Access to resources Recommend Favorite

A long-term prospective randomized controlled study of non-specific interstitial pneumonia (NSIP) treatment in scleroderma

By Domiciano Diogo   Bonfá Eloisa   Borges Claudia   Kairalla Ronaldo   Capelozzi Vera   Parra Edwin   Christmann Romy  

Clinical Rheumatology, Vol. 30, Iss. 2, 2011-02 ,pp. : 223-229

Springer Publishing Company

Access to resources Recommend Favorite